Anti-angiogenic Ophthalmic Agents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
- Transparency Market Research
- Ophthalmic Devices
Global Anti-angiogenic Ophthalmic Agents Market: Overview
Anti-angiogenic ophthalmic agents mimic vascular endothelial growth factor (VEGF) antagonists. Due to the stimulation of vascular endothelial growth factor, new blood vessels are generated by a process known as neovascularization when the retinal pigment cells become dry, and ischemic. In the retina, leaking is caused if new blood vessels are not generated properly. This leads to the loss of vision. Anti-angiogenic ophthalmic agents are used to stop neovascularization in age-related macular degeneration. Anti-angiogenic ophthalmic agents are used for the treatment of myopic choroidal neovascularization, macular edema, macular degeneration, diabetic retinopathy, and diabetic macular edema. Diabetes patients are prone to diabetic macular edema (DME). DME is when blood vessels in the retina begin to leak into the macula, which causes swelling and thickening. The swelling does not cause blindness; however, it can lead to severe loss of central vision. Long-term diabetes leads to progressive damage to the retina, which can cause blindness. This condition is known as diabetic retinopathy. When macula, the central part of the retina is affected it causes decrease visual acuity and possible loss of central vision. This indication is known as macular degeneration.
If blood vessels in the eye start to leak fluids in the macula then this condition is characterized by macular edema. In this indication, there is swelling and thickening of macula due to accumulation of fluid in the central part of the retina, which leads to distorted and blurred vision. Visual impairment due to complications in myopia is known as myopic choroidal neovascularization. Between the sclera and the retina, there is choroid that is the vascular layer of the eye. Creation of new blood vessels in the choroid of the myopic eye is due to the elongation of antero-posterior axis that causes stress. Decrease in visual acuity is caused due to this neovascularization.
Global Anti-angiogenic Ophthalmic Agents Market: Drivers and Restraints
Increasing prevalence of diabetic macular edema, diabetic retinopathy, macular degeneration, macular edema, myopic choroidal neovascularization across the globe drives the anti-angiogenic ophthalmic agents market. The U.S. National Library of Medicine, National Institutes of Health states that approximately there are nearly 285 million diabetes mellitus patients globally, about one-third have signs of diabetic retinopathy. According to National Institutes of Health of U.S. the National Eye Institute, in the U.S., more than 1.75 million individuals are affected by macular degeneration caused due to rapid increase in the aging US population, this number is anticipated to increase to 3 million by 2020.
Global Anti-angiogenic Ophthalmic Agents Market: Key Segments
The global anti-angiogenic ophthalmic agents market can be segmented based on indication type, distribution channel, and region. In terms of indication type, the anti-angiogenic ophthalmic agents market can be categorized into myopic choroidal neovascularization, macular edema, macular degeneration, diabetic retinopathy, and diabetic macular edema. Based on distribution channel, the anti-angiogenic ophthalmic agents market can be divided into retail pharmacies, online pharmacies, and hospital pharmacies.
Geographically, the global anti-angiogenic ophthalmic agents market can be segregated into Latin America, Asia Pacific, Europe, North America, and Middle East & Africa. North America held the large Anti-angiogenic ophthalmic agents market share in 2016, due to increasing prevalence of DME in the region. According to the U.S. National Library of Medicine, National Institutes of Health, DME is a leading cause of blindness in young adults in developed countries. Anti-angiogenic ophthalmic agents affects 28% of type 2, and 12% of type 1 diabetic patients. Europe held the second large share of the Anti-angiogenic ophthalmic agents market in 2016, owing to increasing prevalence of myopic choroidal neovascularization were affected in 2010 in the region. The Anti-angiogenic ophthalmic agents market in Asia Pacific is anticipated to grow at a considerable pace during the forecast period. The Anti-angiogenic ophthalmic agents market in Middle East & Africa and Latin America is anticipated to grow at a considerable pace during the forecast period owing to increasing prevalence of diabetes.
Global Anti-angiogenic Ophthalmic Agents Market: Key Players
Key players of the global anti-angiogenic ophthalmic agents market include Gilead Sciences, Inc., Eyetech Inc., Becton, Dickinson and Company, Regeneron Pharmaceuticals, Inc., and Genentech, Inc.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Ophthalmic Devices
Medical DevicesNebulizers-Medical Devices Pipeline Product Landscape, 2021